We replicated the previously reported diverging patterns of DNA methylation-based age acceleration by tumor subtype that were primarily based on European patients, with luminal tumors displaying increased age acceleration while HER2-enriched/basal-like tumors exhibiting age deceleration. This evidence concerns the gene ERBB2 and neoplasm.